Genotyping of HLA-class-I by PCR-SSP of Iraqi Breast Cancer Patients
|
|
- Rosemary Black
- 6 years ago
- Views:
Transcription
1 Genotyping of HLA-class-I by PCR-SSP of Iraqi Breast Cancer Patients Ahmed A.Al-Hassan 1 PhD, Nidhal Abdul Muhymen 1 MSc;PhD,Ala'a Ghany Hussien 2 FICMS, Ameera J. Al-Nema 3 MBChB. Abstract Background: The aetiology of breast cancer is multifactorial, in which genetic predisposition; environmental factors, hormones and even the infectious agents are thought to interact in the manifestation of disease. In this regard, alleles of HLA are important immunogenetic risk factors, but their associations show different frequencies in different populations. Objectives: This study was established to shed light on the possible association of HLA class I alleles with BC in Iraqi female patients. Subjects and Methods: The study included 60 subjects: 30 breast cancer patients, 12 patients with benign breast lesions as first control and 18 apparently healthy subjects as second control. Polymerase chain reaction-specific sequence primers (PCR- SSP) assay was conducted to assess HLA- typing. Introduction With more than 1 million new cases in the world each year, breast cancer (BC) is the commonest malignancy and the leading cause of cancer death in women (1). In Iraq, the BC is the commonest cancer in females; furthermore, currently there is a general trend towards an increase the incidence of disease in females of younger ages (2). Human based studies have suggested that the host genetics predisposition is important in disease pathogenesis and protection (3), and considering the importance of immune surveillance during tumorigenesis (4, 5), 1 Dept. Medical Microbiology, College of Medicine, Al-Nahrain University, 2 Dept. Pathology, College of Medicine, Al-Nahrain University, 3 Medico Legal Institute. Address Correspondence to: Dr. Nidhal AbdulMohymen. E- mail: dr.nidhalmohammed@yahoo.com Received: 1 st June 2008, Accepted: 3 rd June Results: Out of 95 HLA class I alleles (A= 24; B= 48; C= 23), one allele (HLA- A* , 09-11N, allele) showed a significant variation between breast cancer patients and control groups (healthy and disease controls) (50% vs. 16.6%, OR=5, EF= 0.40, P= 0.041), (50% vs. 8.3%, OR=11, EF=O.45, P=0.024) respectively. Conclusions: The results demonstrated that HLA- A* , 09-11N, allele may played a role in the etiology of the disease. Keywords: Breast cancer, HLA, PCR. IRAQI J MED SCI, 2009; VOL.7 (3):5-12 some individuals who inherit specific alleles or haplotypes of the highly polymorphic human leukocyte antigen (HLA) system may be exposed or may resist to specific types of cancers (6-9). Breast cancer occurrence differs among women of different racial and/or ethnic groups, and accordingly, several HLA associations have linked HLA system with susceptibility or protection in the disease. However, the studies have been consistent with respect to the influence of these alleles in immune clearance of tumor cells in a way that could affect BC development. Therefore, HLA genotypes have been suggested to be a biologically based risk factor for BC (10, 11). In the present study, the polymorphism of HLA-A, - B and -Cw alleles was analyzed in a sample of Iraqi females with BC using the PCR SSP method. Iraqi Journal of Medical Sciences 5
2 Subjects and Methods Subjects: Thirty breast cancer female patients (invasive ductal carcinoma, invasive lobular carcinoma and in situ ductal carcinoma), with an age range of years, were eligible for this study. The patients were admitted for surgery at Al-Kadhimia Teaching Hospital and Nursing Home Hospital (Medical City) in Baghdad, for the period March March Pathological data (histologic tumor type grade, tumor stage and lymph node status) were obtained from the medical records of patients and validated by an experienced histopathologist. Two control groups were included: 12females with benign breast lesions (BBL) (6 cases with fibrocystic disease and 6 with fibroadenoma) and 18 apparently healthy females. The latter subjects had no history or clinical evidence of any breast lesions and matched by age and ethnic backgrounds to BC patients. Methods: Blood collection Two milliliters of venous blood with EDTA as anticoagulant were collected from each subject. DNA extraction Extraction of DNA from peripheral blood was done according to the modified method of Miller (12), using the EXTRA-GENE-I kit (BAG- Germany), which is the most suitable method for isolation since pure DNA can be obtained from whole blood in a short time without the use of toxic chemicals or solvents. PCR amplification HLA-genotyping was performed by PCR-SSP according to a method presented by Olerup and Zetterquist (13,14), using low resolution typing kits (HISTO TYPE / DNA-SSP Kits-BAG- Germany). Appropriate amounts of DNA and Taq polymerase (Recombinant Taq polymerase from QIAGEN-company) were added to pre-aliquoted primers and PCR conditions were set according to the manufacturer instructions. Detection of PCR products PCR products were loaded in 2 % agarose gel containing 0.5 mg/ml ethidium bromide, electrophoresed for 25 min at 12 V/cm, and examined under ultraviolet light. The individual alleles were assigned for the specific pattern of appropriately sized bands. Statistical analysis The results were presented in terms of percentage frequencies, and alleles showing variations between patients and controls were further presented in terms of odds ratio (OR), etiological fraction (EF) and preventive fraction (PF). The significance of these differences were assessed by fisher, s exact probability (P), which was corrected for the number of alleles at each locus (15,16). Results In this study the mean age of BC patients was 48.1 years with a range of years, while the mean age of BBL was years with a range of years. In the PCR-SSP method, 24 HLA- A, 48 HLA-B and 23 HLA-Cw specific primer mixes were employed as well as, a negative control and ladder mixes. A successful amplification resulted in the generation of a defined length band as a positive internal control in all lanes except the negative control lane, and when there was no amplification, there was no band. In addition, a positive specific amplification resulted in the generation of a specific band in addition to an internal control band (Figures 1-2). The observed percentage frequencies of HLA-A,-B and Cw alleles in the investigated groups are given in tables 1, 2 and 3, respectively, while allele showing a significant Iraqi Journal of Medical Sciences 6
3 variation is presented in table 4. Out of 95 HLA-class I alleles, one allele (A* , 09-11N, 13-16) showed a significant variation between patients and controls. In breast cancer patients, the A* ,09-11N,13-16 allele accounted to 50% of patients, while its frequency in benign breast lesion patients and healthy controls was 8.3%, 16.6% respectively, such difference was significant (P= 0.024, P=0.041), and associated with OR and EF values of (11,5) and (0.45, O.40) respectively. However, the corrected probability of these differences failed to attend a significant level. Discussion The role of genetic factors in the etiology of BC was documented decades ago. As a result, the investigative efforts have focused on the genetic markers of susceptibility to this disease. In particular, HLA system plays a pivotal role in cellular immunity and may be an important genetically determined host trait (17, 18). This study is the first attempt on the association between HLA class I alleles and BC in Iraqi patients, in which the alleles were characterized by PCR-SSP. In the present work, there was a significant positive association between HLA- A* , 09-11N, allele and BC as compared with healthy control. The OR for this allele was 5 and this means that the individuals with A* , 09-11N, allele have 5 times a greater chance of acquiring BC than those of the same population who lack it. Also, in the present study the comparison of BC patients with a second control (patient control) revealed a significant increased frequency of A* , 09-11N, allele in BC patients. Therefore, this association of BC with A* , 09-11N, allele may be considered important in the etiology of BC because it was based in the comparison with two different control groups and unlikely to be attributed to chance factor. In the context of anti-tumor immunity, HLA- A* ,09-11N,13-16 allele may differ in its ability to present p53 or other relevant tumor associated antigen derived peptides, thereby contributing to the modulation of risk to develop BC. A similar mechanism has been suggested to operate in case of progression of cervical cancer in HLA-B7 positive patients harboring an HPV variant with uniquely altered peptide sequence of the E6 oncoprotein. The association of HLA- A* ,09-11N,13-16 allele with breast cancer may also be due to other risk modulating loci that are in linkage disequilibrium with this allele (19). This result is at variance with some other studies, in serological studies, Bouillenne and Deneufbourg, in (1979), identified HLA - A28 as high risk allele amongst nulliparous pre-menopausal breast cancer patients (20). A study from India reported a higher frequency of HLA-A2, in breast cancer patients whereas HLA-A11, HLA-Aw19 were suggested to be protective alleles (21). In addition, Glaser (2005) noticed that the risk increased for whites with A-23 and African-Americans with A-32 after adjustment for age and reproductive risk factors (22). In the absence of similar findings elsewhere, we must suppose that this association is local, and since, HLA class I proteins are entrusted with the presentation of viral antigens, the A* ,09-11N,13-16 allele could in fact be related with a viral agent, which in turn is associated with breast cancer in this part of the world. In agreement with this scope, different research groups have recently reported Iraqi Journal of Medical Sciences 7
4 the involvement of a viral agent in human mammary carcinogenesis (murine mammary tumor virus) (23, 24). In conclusion, these findings demonstrated that HLA- A* , 09-11N, allele might play a role in BC susceptibility, suggesting HLAbased different etiopathogenesis. Figure 1: Electrophoresis of HLA-A alleles amplification by PCR-SSP. *Lane M represent 1 Kb DNA Ladder, **Lane-C represent negative control. HLA-A genotyping was obtained by using primers that detect the following alleles as they were present in the numbered wells, respectively:1= A1/ - / Null; 2= A2 /Low A2 / A203 / - / A210 / Null; 3= A2 / - ; 4= A3 / Null /- ; 5= A11 / - / Null ; 6= A23(9) / - / Null ; 7= A24(9) / Low A24/ Null / A2403 / A9 / - ; 8= A24(9) / - ; 9= A25(10) / - ; 10= A26(10),A10,Null ; 11= A26(10) ; 12= A29(19) / Null /- ; 13= A30(19) / - ; 14= A31(19) / - ; 15= - / A31(19) ; 16= A32(19) / - ; 17= A34(10) / - ; 18= A36 / - ; 19= A43 ; 20= A66(10) / - ; 21= A68(28) / A28 / Null / - ; 22= A69(28) ; 23= A74(19) / - ; 24= A80. Figure 2: Electrophoresis of HLA-A alleles amplification by PCR-SSP. *Lane M represent 1 Kb DNA Ladder, **Lane-C represent negative control. HLA-A genotyping was obtained by using primers that detect the following alleles as they were present in the numbered wells, respectively:1= A1/ - / Null; 2= A2 /Low A2 / A203 / - / A210 / Null; 3= A2 / - ; 4= A3 / Null /- ; 5= A11 / - / Null ; 6= A23(9) / - / Null ; 7= A24(9) / Low A24/ Null / A2403 / A9 / - ; 8= A24(9) / - ; 9= A25(10) / - ; 10= A26(10),A10,Null ; 11= A26(10) ; 12= A29(19) / Null /- ; 13= A30(19) / - ; 14= A31(19) / - ; 15= - / A31(19) ; 16= A32(19) / - ; 17= A34(10) / - ; 18= A36 / - ; 19= A43 ; 20= A66(10) / - ; 21= A68(28) / A28 / Null / - ; 22= A69(28) ; 23= A74(19) / - ; 24= A80. Iraqi Journal of Medical Sciences 8
5 Table 1: Observed percentage frequencies of HLA-A alleles in healthy controls, breast cancer patients and benign breast lesion. Specificities Healthy Cases (breast Benign breast controls (n=18) Ca) (n=30) lesion (n=12) HLA-A-Allele N % N % N % A* N, N,06-11N,12,14,15N A* ,24-33, ,47,49-54,57-61,63,64,66-69,71-77,79-86 A*0246,48, A* ,09-11N, A* *1116,20,21N A*2301,02, N,08N,10,11N,12 A*2408,21,29, A* ,03,05, ,10-12,14-18,21-25N, A* *3004,06-14L, A*310102,02,05,06,08,09, ,12 A* /B* A*3301, A* A*6601* A* Blank Table 2: Observed percentage frequencies of HLA-B alleles in healthy controls, breast cancer patients and benign breast lesion. Specificities Healthy Cases (breast Benign breast controls (n=18) Ca) (n=30) lesion (n=12) HLA-B-Allele N % N % N % B* B* B* B*1551, B* B* ,03,05,07,08, ,17,23, 24,29,30,32,33,36,38,40N- 42,48,50,52, 53N B*350201,0202,0401,06,0901, ,18 B*3527, B* Iraqi Journal of Medical Sciences 9
6 B*4039, B* B*440301,0302,04,07,13,26,28, ,32,35,36,38,39 B* B* B* B* B* B*5001, B*510102,0202, B*520101,0103,04,05, B* B* ,08,10-13,17N Blank Table 3: Observed percentage frequencies of HLA-Cw alleles in healthy controls, breast cancer patients and benign breast lesion. Specificities Healthy controls (n=18) Cases(breast Ca) (n=30) Benign breast lesion( n=12) HLA-Cw-Allele N % N % N % Cw* , Cw* , Cw* , Cw* Cw* , N,10-13 Cw* N Cw*0602,03,07,09, Cw*070101,0102,05,06,08, ,16,18,20-22 Cw* , Cw*120301,06,07, Cw* Cw*120402, Cw* Cw* Cw ,020102,10,13, ,19 Blank ٥ 50 Iraqi Journal of Medical Sciences 10
7 Table 4: HLA- A* , 09-11N, allele showing significant variations between breast cancer patients and controls. Patients Controls Statistical HLA- evaluations A* ,09-11N,13-16 N % N % Odds EF P ratio Breast cancer patients vs. healthy controls Breast cancer patients vs. benign breast lesion patients EF: Etiological fraction; P: Fisher's exact two-sided Probability. References 1. Ackerman LV, Rosai J. Breast In: Rosai and Ackerman's Surgical Pathology, 9 th ed, Ackerman LV and Rosai J (eds), Mosby, St Louis, 2004; pp ICB. Results of Iraqi National Cancer Registry, ( ; ; , ). Iraqi Cancer Board ICRC, Ministry of Health Baghdad- Iraq; Shankarkumar U, Ghosh K, Badkere S, Mohanty D. Novel HLA Class I Alleles Associated with Indian leprosy Patients. J Biomed Biotechnol 2003; 3: Ferguson TA, Green DR, Griffith TS. Cell death and immune privilege. Int Rev Immunol 2002; 21: Igney FH, Krammer PH. Death and antideath: tumor resistance to apoptosis. Nat Rev Cancer 2002; 2: Pellegris G, Illeni MT, Vaglini M. HLA antigens in malignant melanoma patients. Tumori, 1980; 66: Bidwell JL, Soong TW, Raymond PA. HLA genotyping of colorectal carcinoma in the Chinese population. Hum Immunol 1992; 34: Wu MS, Hsieh RP, Huang SP. Association of HLA-DQB1*0301 and HLA- DQB1*0602 with different subtypes of gastric cancer in Taiwan. Jpn J Cancer Res, 2002; 93: Harrath AB, Loueslati BY, Troudi W, Hmida S, Sedkaoui S, Dridi A, Jridi A. HLA class II polymorphism: Protective or risk factors to breast cancer in Tunisia Pathology. Oncology Research 2006; 12, No (2), Glaser S. Immune function genes and racedifferences in breast cancer. NorthernCaliforniaCancerCenter; wwcbcrporg/research/pagegrantasp?grant_id= Glaser S, Join EM, Clarke CA, Erlich HA. Human leukocyte antigen genotype as a contributor to racial/ethnic differences in breast cancer: A population based, molecular epidemiologic study. Northern california cancer center unioncity 2004; Annual rept 2 June June Miller SA, Dykes DD, Polesky IF. Asimple salting out procedure for extracting DNA from human nucleated cells. Nucl Acid Res 1988; 16: Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with PCR-SSP in two hours. Tissue Antigens 1992; 39: Olerup O, Zetterquist H.DR lowresolution PCR-SSP typing-a correction and an update. Tissue Antigens 1993; 41: Emery AEH. Methodology in medical genetics: An introduction to statistical methods. First edition, UK, Churchill Livingstone 1976; Sorlie DE. Medical biostatistics and epidemiology: Examination and Board review First ed, Norwalk, Connecticut, Appleton and Lange 1995; Fossum B, Breivik J, Meling GI. A K-ras 13Gly-->Asp mutation is recognized by HLA- DQ7 restricted T cells in a patient with colorectal cancer Modifying effect of DQ7 on established cancers harboring this mutation. Int J Cancer 1994; 58, Bateman A, Howell WM. Human leukocyte antigens and cancer: is it in our genes. J Pathol, 1999; 188: Gopalkrishnan L, Patil S, Chhaya S, Badwe R, Joshi N. HLA alleles in pre- Iraqi Journal of Medical Sciences 11
8 menopausal breast cancer patients from western India. Indian J Med Res, 124, September, 2006; pp Bouillenne C, Deneufbourg JM. Positive correlation between breast cancer incidence and HLA antigens. Oncology 1979; 36: Biswal BM, Kumar R, Julka PK, Sharma U, Vaidya MC. Human leucocytic antigens (HLA) in breast cancer. Indian J Med Sci 1998; 52: Glaser SL. HLA genotype as a contributor to racial/ethnic differences in BC: A population based molecular epidemiologic study. Annual rept June rd&metadataprefix=html&identifier=ada Pogo BG-T. A retrovirus similar to MMTV associated with human breast cancer. Breast Cancer Res 2001; 3, p A Stewart A. MMTV-related env sequences in human breast tumor. Int J Cancer 2003; 10 (106), p 138. Iraqi Journal of Medical Sciences 12
Genotyping of HLA-class-I and II by PCR-SSP of Patients with. Recurrent Aphthous Stomatitis
Original Article Genotyping of HLA-class-I and II by PCR-SSP of Patients with * Mustafa M. Saliah** Ahmed A.Al-Hassan*** Ammra J. Al-Nema**** Ahmed Kadem***** BSc, PhD BDS Vet, PhD MD, MSc MSc Fac Med
More informationHLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma
HLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma Arezou Sayad 1, Mohammad Taghi Akbari 2**, Mahshid Mehdizadeh 3,4, Mohammad Taheri 1, Abbas Hajifathali 3* 1 Department of Medical
More informationCompleting the CIBMTR Confirmation of HLA Typing Form (Form 2005)
Completing the CIBMTR Confirmation of HLA Typing Form (Form 2005) Stephen Spellman Research Manager NMDP Scientific Services Maria Brown Scientific Services Specialist Data Management Conference 2007 1
More informationAssociation of HLA-DRB alleles and pulmonary tuberculosis in North Chinese patients
Association of HLA-DRB alleles and pulmonary tuberculosis in North Chinese patients G.L. Shi, X.L. Hu, L. Yang, C.L. Rong, Y.L. Guo and C.X. Song Department of Clinical Immunology Laboratory, Beijing Tuberculosis
More informationAnalysis of HLA-A, HLA-B and HLA-DRB1 alleles in Chinese patients with lung cancer
Analysis of HLA-A, HLA-B and HLA-DRB1 alleles in Chinese patients with lung cancer L. Yang 1, L.J. Wang 3, G.L. Shi 2, L. Ni 3, C.X. Song 2, Z.X. Zhang 3 and S.F. Xu 1 1 Department of Thoracic Surgeon,
More informationASSESSMENT OF THE RISK FOR TYPE 1 DIABETES MELLITUS CONFERRED BY HLA CLASS II GENES. Irina Durbală
ASSESSMENT OF THE RISK FOR TYPE 1 DIABETES MELLITUS CONFERRED BY HLA CLASS II GENES Summary Irina Durbală CELL AND MOLECULAR BIOLOGY DEPARTMENT FACULTY OF MEDICINE, OVIDIUS UNIVERSITY CONSTANŢA Class II
More informationThe Human Major Histocompatibility Complex
The Human Major Histocompatibility Complex 1 Location and Organization of the HLA Complex on Chromosome 6 NEJM 343(10):702-9 2 Inheritance of the HLA Complex Haplotype Inheritance (Family Study) 3 Structure
More informationImmunogenetics in SARS: a casecontrol
RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES MHL Ng 吳香玲 SH Cheng 鄭淑恆 KM Lau 劉建盟 GM Leung 梁卓偉 US Khoo 邱瑋璇 BCW Zee 徐仲鍈 JJY Sung 沈祖堯 Key Messages 1. Human leukocyte antigen (HLA) genotypes from 102
More informationHLA Class I and II Genotyping by PCR-SSO in Patients with Type-1 Diabetes Mellitus
HLA THE CLASS IRAQI POSTGRADUATE I AND II GENOTYPING MEDICAL JOURNAL HLA Class I and II Genotyping by PCR-SSO in Patients with Type-1 Diabetes Mellitus Ahmed A. Al-Hassan*, Anwar Mohammad*, Batool H. Al-Ghurabi**,
More informationHLA and more. Ilias I.N. Doxiadis. Geneva 03/04/2012.
www.ebmt.org HLA and more Ilias I.N. Doxiadis Geneva 03/04/2012 HLA and more HLA and more / Doxiadis 2 Topic of the day Compatibility testing is a type of testing used to ensure compatibility of the system/application/website
More informationDistribution of HLA Antigens Class I and II in Iraqi Arab population
Distribution of HLA s Class I and II in Iraqi Arab population *Ahmed A.A. Al-Hassan, MSc, Immunology ; **Sana a Al-Naseri, MD, ph.d, immunopathology *** Batool H. Al-Ghurabi, ph.d, Immunology **** Mohammed
More informationPolymerase chain reaction based human leucocyte antigen genotyping for the investigation of suspected gastrointestinal biopsy contamination
Gut 1999;45:259 263 259 Histopathology, Southampton General Hospital, Southampton, UK A C Bateman J M Theaker Histocompatibility and Immunogenetics Laboratory, Southampton General Hospital, Southampton,
More informationNovel HLA Class I Alleles Associated with Indian Leprosy Patients
Biomedicine and Biotechnology 2003:3 (2003) 208 211 PII. S1110724303210019 http://jbb.hindawi.com RESEARCH ARTICLE Novel HLA Class I Alleles Associated with Indian Leprosy Patients U. Shankarkumar, K.
More informationExtensive studies on polymerase chain reactionsequence-specific. DRB1* allele profiling in non insulin dependent diabetes mellitus (Indian population)
African Journal of Pharmacy and Pharmacology Vol. 6(10), pp. 685-691, 15 March, 2012 Available online at http://www.academicjournals.org/ajpp DOI: 10.5897/AJPP11.052 ISSN 1996-0816 2012 Academic Journals
More informationAllelic and Haplotype Frequencies of the p53 Polymorphisms in Brain Tumor Patients
Physiol. Res. 51: 59-64, 2002 Allelic and Haplotype Frequencies of the p53 Polymorphisms in Brain Tumor Patients E. BIROŠ, I. KALINA, A. KOHÚT 1, E. BOGYIOVÁ 2, J. ŠALAGOVIČ, I. ŠULLA 3 Department of Medical
More informationAward Number: W81XWH TITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer
AD Award Number: W81XWH-04-1-0579 TITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer PRINCIPAL INVESTIGATOR: Yuichiro Tanaka, Ph.D. Rajvir Dahiya, Ph.D. CONTRACTING ORGANIZATION:
More informationProf. Dr. Kutikuppala Surya Rao MD.,PhD.,MNAMS.,FHM(CMC Vellore) DFM.,FCGP.,FRCP(London)
A Study of HPV genotypes in HIV-Positive Women for early detection of risk for cervical cancers in Andhrapradesh, India. Prof. Dr. Kutikuppala Surya Rao MD.,PhD.,MNAMS.,FHM(CMC Vellore) DFM.,FCGP.,FRCP(London)
More informationIndian Journal of Nephrology Indian J Nephrol 2001;11: 88-97
88 Indian Journal of Nephrology Indian J Nephrol 2001;11: 88-97 ARTICLE HLA gene and haplotype frequency in renal transplant recipients and donors of Uttar Pradesh (North India) S Agrawal, AK Singh, RK
More informationHLA haplotype A33-B58-Cw10 may modulate radiographic development of bamboo spine in Taiwanese patients with primary ankylosing spondylitis
Disease Markers 26 (2009) 93 96 93 DOI 10.3233/DMA-2009-0619 IOS Press HLA haplotype A33-B58-Cw10 may modulate radiographic development of bamboo spine in Taiwanese patients with primary ankylosing spondylitis
More informationJ. Environ. Res. Develop. Journal of Environmental Research And Development Vol. 8 No. 3A, January-March 2014
ASSOCIATION OF THE 45 T/G AND 276 G/T POLYMOR- PHISMS IN THE ADIPONECTIN GENE WITH TYPE 2 DIABETES IN SOUTH INDIAN POPULATION Thirunavukkarasu A.,* Nithya R., 1 Muthukumaran K. and Sivasankari C. 2 1.
More informationHLA TYPING AND EXPRESSION: POTENTIAL MARKER FOR IDENTIFYING EARLY DYSPLASIA AND STRATIFYING THE RISK FOR IBD-CANCER
HLA TYPING AND EXPRESSION: POTENTIAL MARKER FOR IDENTIFYING EARLY DYSPLASIA AND STRATIFYING THE RISK FOR IBD-CANCER Megan Garrity, S. Breanndan Moore, M.D., William Sandborn, M.D., Vernon Pankratz, Ph.D.,
More informationValidation Report: VERSA Mini PCR Workstation Reverse Transcription of Avian Flu RNA and Amplification of cdna & Detection of H5N1
I. Objectives Validation Report: VERSA Mini PCR Workstation Reverse Transcription of Avian Flu RNA and Amplification of cdna & Detection of H5N1 1. To ensure stability of RNA (highly thermolabile and degradatively
More informationTITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer
AD Award Number: W81XWH-04-1-0579 TITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer PRINCIPAL INVESTIGATOR: Yuichiro Tanaka, Ph.D. CONTRACTING ORGANIZATION: Northern California
More informationHLA-DQA1 and DQB1 Genotyping in Individuals with Family History of Gastritis
ADVANCES IN BIORESEARCH, Vol. 2 [1] June 2011: 40-46 Society of Education, India http://www.soeagra.com/abr.htm ISSN 0976-4585 RESEARCH ARTICLE HLA-DQA1 and DQB1 Genotyping in with Family Nibras S. Al-Ammar
More informationRole of Paired Box9 (PAX9) (rs ) and Muscle Segment Homeobox1 (MSX1) (581C>T) Gene Polymorphisms in Tooth Agenesis
EC Dental Science Special Issue - 2017 Role of Paired Box9 (PAX9) (rs2073245) and Muscle Segment Homeobox1 (MSX1) (581C>T) Gene Polymorphisms in Tooth Agenesis Research Article Dr. Sonam Sethi 1, Dr. Anmol
More informationOriginal Article The programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with non-small cell lung cancer risk in a Chinese Han population
Int J Clin Exp Med 2014;7(12):5832-5836 www.ijcem.com /ISSN:1940-5901/IJCEM0002117 Original Article The programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with non-small cell lung cancer risk
More informationHead and Neck Squamous Subtypes
1 Head and Neck Squamous Subtypes Adel K. El-Naggar, M.D., Ph.D. The University of Texas MD Anderson Cancer Center, Houston, Texas HNSCC 5 th -6 th most common cancer 400,000/year 50% mortality Considerable
More informationFONS Nové sekvenační technologie vklinickédiagnostice?
FONS 2010 Nové sekvenační technologie vklinickédiagnostice? Sekvenování amplikonů Sequence capture Celogenomové sekvenování FONS 2010 Sekvenování amplikonů Amplicon sequencing - amplicon sequencing enables
More informationDiversity and Frequencies of HLA Class I and Class II Genes of an East African Population
Open Journal of Genetics, 2014, 4, 99-124 Published Online April 2014 in SciRes. http://www.scirp.org/journal/ojgen http://dx.doi.org/10.4236/ojgen.2014.42013 Diversity and Frequencies of HLA Class I and
More information1. INTRODUCTION. Profile of HLA-DQ allele in a sample of Iraqi Celiac disease Patients. ABSTRACT
Profile of HLA-DQ allele in a sample of Iraqi Celiac disease Patients. Noor Sabah Haphed 1, Ekhlass N.Ali 2 and Batool Mutar Mahdi 3 1, 2, PDepartment of Biology, College of Science, AL-Mustansyria University,
More informationGastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR
Gastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR Pages with reference to book, From 305 To 307 Irshad N. Soomro,Samina Noorali,Syed Abdul Aziz,Suhail Muzaffar,Shahid
More informationHuman leukocyte antigen-b27 alleles in Xinjiang Uygur patients with ankylosing spondylitis
Human leukocyte antigen-b27 alleles in Xinjiang Uygur patients with ankylosing spondylitis H.-Y. Zou, W.-Z. Yu, Z. Wang, J. He and M. Jiao Institute of Clinical Medicine, Urumqi General Hospital, Lanzhou
More informationLearning Objectives. ! At the end of the presentation,students will be able to:
Learning Objectives! At the end of the presentation,students will be able to: Define Breast Cancer Identify the controllable and uncontrollable risk factors of breast cancer Recognize the 4 stages of breast
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Clinical Transplantation Laboratory (CTL) 3rd Floor Tower Wing Guy's Hospital SE9 1RT Contact: Jeremy Skinner Tel: +44 (0)2071881713 E-Mail:
More informationCitation for published version (APA): Lutke Holzik, M. F. (2007). Genetic predisposition to testicular cancer s.n.
University of Groningen Genetic predisposition to testicular cancer Lutke Holzik, Martijn Frederik IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite
More informationMultiple Fibroadenomas Harboring Carcinoma in Situ in a Woman with a Familty History of Breast/ Ovarian Cancer
Multiple Fibroadenomas Harboring Carcinoma in Situ in a Woman with a Familty History of Breast/ Ovarian Cancer A Kuijper SS Preisler-Adams FD Rahusen JJP Gille E van der Wall PJ van Diest J Clin Pathol
More informationHLA-C, DRB1 and DQB1 alleles involved in genetic predisposition to psoriasis vulgaris in the Slovak population
Folia Microbiol (2013) 58:319 324 DOI 10.1007/s12223-012-0213-7 HLA-C, DRB1 and DQB1 alleles involved in genetic predisposition to psoriasis vulgaris in the Slovak population Ivana Shawkatová & Juraj Javor
More informationBST227 Introduction to Statistical Genetics. Lecture 4: Introduction to linkage and association analysis
BST227 Introduction to Statistical Genetics Lecture 4: Introduction to linkage and association analysis 1 Housekeeping Homework #1 due today Homework #2 posted (due Monday) Lab at 5:30PM today (FXB G13)
More informationHLA class II DRB1 and DQB1 allelic polymorphism and sclerosing lymphocytic lobulitis of the breast
J Clin Pathol 1999;52:445 449 445 Department of Histopathology, Southampton University Hospitals, Southampton, UK A C Bateman J M Theaker Wessex Histocompatibility Laboratory, Southampton University Hospitals
More informationInvestigation of Human Leukocyte Antigen (HLA) Class I and II Alleles and Hepatitis C Virus (HCV) Genotypes in Patients Infected with HCV
IBBJ Winter 2018, Vol 4, No 1 Original Article Investigation of Human Leukocyte Antigen (HLA) Class I and II Alleles and Hepatitis C Virus (HCV) Genotypes in Patients Infected with HCV Abeer A. Sharaf
More informationValidation of the MIA FORA NGS FLEX Assay Using Buccal Swabs as the Sample Source
S. Krishnakumar, M. Li, C. Wang, M, Osada, R. Kuehn, M. Fukushima and Y. Thorstenson Immucor, Inc. S. Krishnakumar, M. Li, C. Wang, M, Osada, R. Kuehn, M. Fukushima and Y. Thorstenson Immucor, Inc. Introduction
More informationChapter 8. Summary. Chapter 8. Summary
Chapter 8 Chapter 8 Summary Summary Summary In CHAPTER 1 an introduction to several aspects of cervical cancer, HPV and their relation with immunology is given. It took almost one-and-a-half centuries
More informationBarriers to Understanding
Behind the Scenes: The Critical Importance of Cancer Cell Pathology and the Pathologist Sherry T. Emery, M.D., Chief of Pathology Northeast Health System Barriers to Understanding Questions for 2010 What
More informationHLA Class II Variants in Chinese Breast Cancer Patients
RESEARCH COMMUNICATION Xue-Xi Yang 1&, Hua-Zheng Pan 2&, Pei-Yi Li 1, Fen-Xia Li 1, Wei-Wen Xu 1, Ying- Shong Wu 1, Guang-Yu Yao 3, Ming Li 1* Abstract Alterations of human leukocyte antigen (HLA) class
More informationAssociation between HLA-DRB1 alleles and susceptibility to chronic hepatitis B in patients of Basrah province, Iraq
African Journal of Biotechnology Vol. 11(21), pp. 4893-4898, 13 March, 2012 Available online at http://www.academicjournals.org/ajb DOI: 10.5897/AJB11.4111 ISSN 1684 5315 2012 Academic Journals Full Length
More informationProfiling HLA motifs by large scale peptide sequencing Agilent Innovators Tour David K. Crockett ARUP Laboratories February 10, 2009
Profiling HLA motifs by large scale peptide sequencing 2009 Agilent Innovators Tour David K. Crockett ARUP Laboratories February 10, 2009 HLA Background The human leukocyte antigen system (HLA) is the
More informationREGULATIONS FOR THE POSTGRADUATE DIPLOMA IN MOLECULAR AND DIAGNOSTIC PATHOLOGY (PDipMDPath)
REGULATIONS FOR THE POSTGRADUATE DIPLOMA IN MOLECULAR AND DIAGNOSTIC PATHOLOGY (PDipMDPath) (See also General Regulations and Regulations for Taught Postgraduate Curricula) M.129 Admission requirements
More informationCytochrome P450 2E1 RsaI/PstI and DraI Polymorphisms Are Risk Factors for Lung Cancer in Mongolian and Han Population in Inner Mongolia
www.springerlink.com Chin J Cancer Res 23(2): 107-111, 2011 107 Original Article Cytochrome 450 2E1 RsaI/stI and DraI olymorphisms Are Risk Factors for Lung Cancer in Mongolian and Han opulation in Inner
More informationGenetics and Genomics in Medicine Chapter 8 Questions
Genetics and Genomics in Medicine Chapter 8 Questions Linkage Analysis Question Question 8.1 Affected members of the pedigree above have an autosomal dominant disorder, and cytogenetic analyses using conventional
More informationCANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)
CANCER Affects 25% of US population Kills 19% of US population (2nd largest killer after heart disease) NOT one disease but 200-300 different defects Etiologic Factors In Cancer: Relative contributions
More informationRelationship Between HLA-DMA, DMB Alleles and Type 1 Diabetes in Chinese
HK J Paediatr (new series) 2005;10:20-25 Relationship Between HLA-DMA, DMB Alleles and Type 1 Diabetes in Chinese YM SANG, C YAN, C ZHU, GC NI, YM HU Abstract Key words The Human Leucocyte Antigen (HLA)-DMA
More informationHLA and new technologies. Vicky Van Sandt
HLA and new technologies. Vicky Van Sandt Life-threatning malignant and non malignant blood disorders can be cured by hematopoetic stem cell transplantation (HSCT). GVHD is the 2nd most prevalent cause
More information10/18/2012. A primer in HLA: The who, what, how and why. What?
A primer in HLA: The who, what, how and why What? 1 First recognized in mice during 1930 s and 1940 s. Mouse (murine) experiments with tumors Independent observations were made in humans with leukoagglutinating
More informationMuta onal changes in two randomly selected regions (exon 3 and exon 7) of estrogen receptor beta gene in Iraqi breast cancer female patients
Journal of Genetic and Environmental Resources Conservation, 2014, 2(1): 30 34. www.jgerc.com Muta onal changes in two randomly selected regions (exon 3 and exon 7) of estrogen receptor beta gene in Iraqi
More informationspecific PCR-based HLA class II typing
288 28 Clin Pathol 1997;50:288-293 Department of Histopathology, Southampton General Hospital, Southampton, United Kingdom A C Bateman J M Theaker Wessex Histocompatibility Laboratory, Southampton, United
More informationIMMUNOLOGY. Elementary Knowledge of Major Histocompatibility Complex and HLA Typing
IMMUNOLOGY Elementary Knowledge of Major Histocompatibility Complex and HLA Typing Tapasya Srivastava and Subrata Sinha Department of Biochemistry All India Institute of Medical Sciences New Delhi - 110029
More informationHistocompatibility Evaluations for HSCT at JHMI. M. Sue Leffell, PhD. Professor of Medicine Laboratory Director
Histocompatibility Evaluations for HSCT at JHMI M. Sue Leffell, PhD Professor of Medicine Laboratory Director JHMI Patient Population Adults Peds NMDP data >20,000 HSCT JHMI HSCT Protocols Bone marrow
More informationLack of association of IL-2RA and IL-2RB polymorphisms with rheumatoid arthritis in a Han Chinese population
Lack of association of IL-2RA and IL-2RB polymorphisms with rheumatoid arthritis in a Han Chinese population J. Zhu 1 *, F. He 2 *, D.D. Zhang 2 *, J.Y. Yang 2, J. Cheng 1, R. Wu 1, B. Gong 2, X.Q. Liu
More informationThe Relationship between Minor Histocompatibility Antigens and Graft Versus Host Disease in Unrelated Peripheral Blood Stem Cell Transplants
mhags and GVHD Page 1 The Relationship between Minor Histocompatibility Antigens and Graft Versus Host Disease in Unrelated Peripheral Blood Stem Cell Transplants Running Title: mhags and GVHD Conflict
More informationGenerating Mouse Models of Pancreatic Cancer
Generating Mouse Models of Pancreatic Cancer Aom Isbell http://www2.massgeneral.org/cancerresourceroom/types/gi/index.asp Spring/Summer 1, 2012 Alexandros Tzatsos, MD PhD Bardeesy Lab: Goals and Objectives
More informationDOES THE BRCAX GENE EXIST? FUTURE OUTLOOK
CHAPTER 6 DOES THE BRCAX GENE EXIST? FUTURE OUTLOOK Genetic research aimed at the identification of new breast cancer susceptibility genes is at an interesting crossroad. On the one hand, the existence
More informationVIRUSES AND CANCER Michael Lea
VIRUSES AND CANCER 2010 Michael Lea VIRAL ONCOLOGY - LECTURE OUTLINE 1. Historical Review 2. Viruses Associated with Cancer 3. RNA Tumor Viruses 4. DNA Tumor Viruses HISTORICAL REVIEW Historical Review
More informationTHE ROLE OF ANTIGENS AND HLA CLASS I HAPLOTYPES IN
Open Access Research Journal Medical and Health Science Journal, MHSJ www.academicpublishingplatforms.com ISSN: 1804-1884 (Print) 1805-5014 (Online) Volume 7, 2011, pp. 39-43 THE ROLE OF ANTIGENS AND HLA
More informationMCP-1 gene polymorphisms in North Chinese patients with pulmonary tuberculosis
MCP-1 gene polymorphisms in North Chinese patients with pulmonary tuberculosis G.L. Shi, L. Yang, Y. Sun, Y.J. Yin and C.X. Song Department of Clinical Immunology Laboratory, Beijing Tuberculosis and Thoracic
More informationHEREDITY & CANCER: Breast cancer as a model
HEREDITY & CANCER: Breast cancer as a model Pierre O. Chappuis, MD Divisions of Oncology and Medical Genetics University Hospitals of Geneva, Switzerland Genetics, Cancer and Heredity Cancers are genetic
More informationDocumentation of Changes to EFI Standards: v 5.6.1
Modified Standard B - PERSONNEL QUALIFICATIONS B1.000 The laboratory must employ one or more individuals who meet the qualifications and fulfil the responsibilities of the Director/Co-Director, Technical
More informationConditions. Name : dummy Age/sex : xx Y /x. Lab No : xxxxxxxxx. Rep Centre : xxxxxxxxxxx Ref by : Dr. xxxxxxxxxx
Name : dummy Age/sex : xx Y /x Lab No : xxxxxxxxx Rep Centre : xxxxxxxxxxx Ref by : Dr. xxxxxxxxxx Rec. Date : xx/xx/xx Rep Date : xx/xx/xx GENETIC MAPPING FOR ONCOLOGY Conditions Melanoma Prostate Cancer
More informationAssociation between rs G<C gene polymorphism and susceptibility to pancreatic cancer in a Chinese population
Association between rs9904341 G
More informationCYP19 gene polymorphisms and the susceptibility to breast cancer in Xinjiang Uigur women
CYP19 gene polymorphisms and the susceptibility to breast cancer in Xinjiang Uigur women L. Yang, X.Y. Wang, Y.T. Li, H.L. Wang, T. Wu, B. Wang, Q. Zhao, D. Jinsihan and L.P. Zhu The Department of Mammary
More informationGenetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma
Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma M.J. Wang, Y. Zhu, X.J. Guo and Z.Z. Tian Department of Orthopaedics, Xinxiang Central Hospital, Xinxiang,
More informationAn association analysis of the HLA gene region in latent autoimmune diabetes in adults
Diabetologia (2007) 50:68 73 DOI 10.1007/s00125-006-0513-z SHORT COMMUNICATION An association analysis of the HLA gene region in latent autoimmune diabetes in adults M. Desai & E. Zeggini & V. A. Horton
More informationTrends in molecular diagnostics
Trends in molecular diagnostics Detection of target genes of interest Quantification Infectious diseases HIV Hepatitis C & B TB / MAC Cytomegalovirus Herpes simplex Varicella zoster CT/GC HPV Profiling
More informationAIDS - Knowledge and Dogma. Conditions for the Emergence and Decline of Scientific Theories Congress, July 16/ , Vienna, Austria
AIDS - Knowledge and Dogma Conditions for the Emergence and Decline of Scientific Theories Congress, July 16/17 2010, Vienna, Austria Reliability of PCR to detect genetic sequences from HIV Juan Manuel
More informationHLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol
HLA and antigen presentation Department of Immunology Charles University, 2nd Medical School University Hospital Motol MHC in adaptive immunity Characteristics Specificity Innate For structures shared
More informationANALYSIS OF IL17 AND IL17RA POLYMORPHISMS IN SPANISH PSORIASIS PATIENTS: ASSOCIATION WITH RISK FOR DISEASE.
ANALYSIS OF IL17 AND IL17RA POLYMORPHISMS IN SPANISH PSORIASIS PATIENTS: ASSOCIATION WITH RISK FOR DISEASE. Batalla A, Coto E*, González-Lara L, González- Fernández D, Maldonado-Seral C, García-García
More informationdoi: /s
doi: 10.1007/s10528-008-9185-3 Lack of association of the HbE variant with protection from cerebral malaria in Thailand Izumi Naka 1, Jun Ohashi 1, Pornlada Nuchnoi 2, Hathairad Hananantachai 2, Sornchai
More informationMultistep nature of cancer development. Cancer genes
Multistep nature of cancer development Phenotypic progression loss of control over cell growth/death (neoplasm) invasiveness (carcinoma) distal spread (metastatic tumor) Genetic progression multiple genetic
More informationHLA-DRB1*1101: A Significant Risk Factor for Sarcoidosis in Blacks and Whites
Am. J. Hum. Genet. 73:720 735, 2003 HLA-DRB1*1101: A Significant Risk Factor for Sarcoidosis in Blacks and Whites Milton D. Rossman, 1 Bruce Thompson, 3 Margaret Frederick, 3 Mary Maliarik, 4 Michael C.
More informationCDH1 truncating alterations were detected in all six plasmacytoid-variant bladder tumors analyzed by whole-exome sequencing.
Supplementary Figure 1 CDH1 truncating alterations were detected in all six plasmacytoid-variant bladder tumors analyzed by whole-exome sequencing. Whole-exome sequencing of six plasmacytoid-variant bladder
More informationSFMC Breast Cancer Site Study: 2011
SFMC Breast Cancer Site Study: 2011 Introduction Breast cancer is the most frequently diagnosed cancer among American women, except for skin cancers. It is the second leading cause of cancer death in women,
More informationA factor which brings about a mutation is called a mutagen. Any agent that causes cancer is called a carcinogen and is described as carcinogenic.
Cancer Cancer is one of the most common diseases in the developed world: 1 in 4 deaths are due to cancer 1 in 17 deaths are due to lung cancer Lung cancer is the most common cancer in men Breast cancer
More informationThe Major Histocompatibility Complex (MHC)
The Major Histocompatibility Complex (MHC) An introduction to adaptive immune system before we discuss MHC B cells The main cells of adaptive immune system are: -B cells -T cells B cells: Recognize antigens
More informationInfluence of interleukin-17 gene polymorphisms on the development of pulmonary tuberculosis
Influence of interleukin-17 gene polymorphisms on the development of pulmonary tuberculosis G.-C. Shi and L.-G. Zhang Department of Tuberculosis, The First Affiliated Hospital of Xinxiang Medical University,
More informationTHE IMPACT OF HLA CLASS I ON VIROLOGICAL OUTCOMES OF HBV
THE IMPACT OF HLA CLASS I ON VIROLOGICAL OUTCOMES OF HBV Philippa Matthews Consultant in Infectious Diseases & Microbiology SUPPRESSION CO-EVOLUTION ESCAPE Host factors associated with the clinical course
More informationJOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 1.393, ISSN: , Volume 2, Issue 5, June 2014
CDH1 AND FGFR2 GENE POLYMORPHISMS IN PATIENTS WITH BREAST CANCER MOHAMMAD-REZA JAVAN 1 MILAD ASADI 2 MEHDI MOHEBI 3 ASLANI SAEED 4 VENUS ZAFARI 5 HOMAYUN DOLATKHAH 6 1 Dept. of Biochemistry & Immunology,
More informationInvestigation on ERCC5 genetic polymorphisms and the development of gastric cancer in a Chinese population
Investigation on ERCC5 genetic polymorphisms and the development of gastric cancer in a Chinese population L.Q. Yang 1, Y. Zhang 2 and H.F. Sun 3 1 Department of Gastroenterology, The Second Affiliated
More informationattomol HLA-B*27-Realtime LT 2 Assay for the detection of the human HLA-B*27-locus using LightCycler (Do not use for tissue typing!
attomol HLA-B*27-Realtime LT 2 Assay for the detection of the human HLA-B*27-locus using LightCycler (Do not use for tissue typing!) For in vitro diagnostic use only! 50 determinations Order number: 95
More informationDiseases of the breast (2 of 2) Breast cancer
Diseases of the breast (2 of 2) Breast cancer Epidemiology & etiology The most common type of cancer & the 2 nd most common cause of cancer death in women 1 of 8 women in USA Affects 7% of women Peak at
More informationOriginal Research Article
ASSESSMENT OF HUMAN PAPILLOMA VIRUS SUBTYPES BY POLYMERASE CHAIN REACTION AND THEIR IMPACT ON THE DEGREE OF DYSPLASIA IN ORAL LEUKOPLAKIA Submitted on: XXXX Dr. N. Kannan, Dr Teja Srinivas, Dr. Rakesh
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/49010 holds various files of this Leiden University dissertation. Author: Heide, A. van der Title: Unravelling narcolepsy : from pathophysiology to measuring
More informationMulti-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis
JCM Accepts, published online ahead of print on 30 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.00678-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Multi-clonal origin
More informationSmoking, human papillomavirus infection, and p53 mutation as risk factors in oropharyngeal cancer: a case-control study
RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES Smoking, human papillomavirus infection, and p53 as risk factors in oropharyngeal cancer: a case-control study PKS Chan *, JSY Chor, AC Vlantis, TL
More informationTransplantation. Immunology Unit College of Medicine King Saud University
Transplantation Immunology Unit College of Medicine King Saud University Objectives To understand the diversity among human leukocyte antigens (HLA) or major histocompatibility complex (MHC) To know the
More informationHLA DRB1 and DQB1 Gene Diversity in Maratha Community from Mumbai India
Kamla-Raj 2003 Int J Hum Genet, 3(1): 39-43 (2003) HLA DRB1 and DQB1 Gene Diversity in Maratha Community from Mumbai India U. Shankarkumar *, J. P. Devaraj, K. Ghosh and D. Mohanty HLA Department, Institute
More informationRecent outbreaks of chikungunya in Sri Lanka and the role of Asian Tigers
Recent outbreaks of chikungunya in Sri Lanka and the role of Asian Tigers Introduction CHIK Virus Classification: An ARBOVIRUS Family - Togaviridae Genus Alphavirus ** Enveloped, positive- strand RNA virus.
More informationPHARMACOGENETICS OF BREAST CANCER
PHARMACOGENETICS OF BREAST CANCER MALGORZATA JAREMKO, PhD Mount Sinai School of Medicine, Department of Genetics and Genomic Sciences Outlines Breast cancer therapeutic situation Pharmacogenetics of antiestrogen
More informationSupplemental Figure 1
1 Supplemental Figure 1 Effects of DATE shortening on HGF promoter activity. The HGF promoter region (-1037 to +56) containing wild-type (30As) or truncated DATE (26As, 27As, 28A, 29As) from breast cancer
More informationGreater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute
2008 ANNUAL REPORT Greater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute Cancer Registry Report The Cancer Data Management System/ Cancer Registry collects data on all types of cancer
More informationStudy on Efficacy of Hepatitis B Immunization in Vaccinated Beta thalassemia Children in Tehran
Original Article Iran J Pediatr Jun 2010; Vol 20 (No 2), Pp:211-215 Study on Efficacy of Hepatitis B Immunization in Vaccinated Beta thalassemia Children in Tehran Zohreh Sharifi*, phd; Saeideh Milani,
More information